Searchable abstracts of presentations at key conferences in endocrinology

ea0086p206 | Metabolism, Obesity and Diabetes | SFEBES2022

Circulating levels of adipose-derived lipokines correlate positively with fasting insulin in states of increased insulin insensitivity in humans

Gamwell Jonathan , Riecan Martin , Pinnick Katherine , Kuda Ondrej , Hodson Leanne

Introduction: Palmitoleate, a proposed adipose tissue (AT)-derived lipokine, has been suggested to contribute to glucose homeostasis. However, data relating to the association between circulating palmitoleate and markers of insulin sensitivity in humans are equivocal. Recently, AT-derived fatty acid-hydroxy fatty acids (FAHFAs) have also been suggested to play a role in glucose homeostasis by increasing glucose uptake in AT. Again, data is conflicting for the association betwe...

ea0059p173 | Obesity & metabolism | SFEBES2018

Fructose is metabolised by human subcutaneous adipocytes and can be used as a substrate for de novo lipogenesis

Pinnick Katherine , Cornfield Thomas , Green Charlotte , Hodson Leanne

Introduction: Excessive consumption of free sugars (glucose and fructose) is linked to an increased risk of developing chronic metabolic diseases. Current knowledge of fructose metabolism has focussed on the liver where it is implicated in impaired insulin sensitivity, increased fat accumulation and dyslipidaemia. The long-term effects of elevated fructose consumption on human health are poorly defined and fructose metabolism in subcutaneous adipose tissue, the largest human f...

ea0094p221 | Metabolism, Obesity and Diabetes | SFEBES2023

Crosstalk between preadipocytes and macrophages modulate depot-specific adipose tissue responses to oestrogen

Cresswell Emily , Pinnick Katherine , Bezbradica Mirkovic Jelena , Karpe Fredrik

Fat distribution influences metabolic risk. Accumulation of fat in the upper body increases metabolic risk, while lower body adipose expansion is protective. Oestrogen promotes lower body adiposity; transgender women on oestrogen therapy show increases in gluteal adipose, while transition to the menopause is associated with a shift in fat distribution towards the upper body, concurrent with changes in metabolic risk. Still, mechanisms governing the depot-specific effects of oe...